Care Coordination Program for Dementia
(Co-CARE-AD Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your current treatments, but it's best to confirm with the trial coordinators.
What data supports the effectiveness of the Dementia Care Consultation treatment?
Research shows that care coordination programs for dementia, like the UCLA Alzheimer's and Dementia Care program, can improve behavioral and depressive symptoms in people with dementia and reduce caregiver strain and depression. Additionally, the Partners in Dementia Care program has been shown to help veterans with dementia by reducing unmet needs and feelings of isolation.12345
Is the Care Coordination Program for Dementia safe for humans?
The Care Coordination Program for Dementia, including similar programs like the Care Ecosystem and Memory Care Home Solutions, focuses on improving care and support for people with dementia and their caregivers. These programs have been evaluated for their impact on medication use and adverse health events, showing positive effects on patient care and satisfaction without indicating any safety concerns.46789
How is the Dementia Care Consultation program treatment different from other treatments for dementia?
The Dementia Care Consultation program is unique because it focuses on care coordination through partnerships between medical centers and Alzheimer's Association chapters, using a telephone-based approach to support both individuals with dementia and their caregivers. This program emphasizes ongoing monitoring and long-term relationships, which is different from many treatments that focus solely on the patient without integrating caregiver support.16101112
What is the purpose of this trial?
This is a randomized, pragmatic clinical trial to evaluate the effectiveness of a collaborative care-coordination program embedded in a health plan for people living with Alzheimer's disease and related dementias (ADRD) and their care partners versus usual care. The study population will include community-dwelling Medicare Advantage members living with ADRD and their care partners. Outcomes will be healthcare utilization outcomes of individuals with ADRD and include emergency department visits, outpatient visits, avoidable emergency department visits, and admission to long-term care facilities.
Research Team
Xiaojuan Li, PhD MSPH
Principal Investigator
Harvard Pilgrim Health Care Institute
Richard Platt, MD MS
Principal Investigator
Harvard Pilgrim Health Care Institute
Eligibility Criteria
This trial is for community-dwelling individuals enrolled in the Tufts Health Plan Medicare Advantage who have Alzheimer's disease or related dementias, along with their caregivers. Participants must meet certain health plan criteria to join.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a collaborative care-coordination program or routine care
Follow-up
Participants are monitored for healthcare utilization outcomes, including emergency department visits and admissions to long-term care facilities
Treatment Details
Interventions
- Dementia Care Consultation program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Harvard Pilgrim Health Care
Lead Sponsor
Tufts Health Plan
Collaborator
National Institute on Aging (NIA)
Collaborator